David Leclercq, general manager of Mundipharma Colombia, reveals his passion for both the Colombian affiliate and the welfare of the Colombian people and gives insight into operating a new pharmaceutical outfit in a highly transformative healthcare environment.
You were appointed General Manager in Colombia back in 2014; what have been your main priorities since then?
"Colombian pharmaceutical firms are very focssed on the early treatment of patients and medical education campaigns that are beginning to spread across the region."
